Prolight Diagnostics AB

Equities

PRLD

SE0003618230

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
0.133 ^SEK	-6.34%		-10.74%	-55.81%

05-17	Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	MT
02-21	Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Prolight Diagnostics AB Reports Earnings Results for the Ten Months Ended December 31, 2022

April 19, 2023

Prolight Diagnostics AB (publ) reported earnings results for the ten months ended December 31, 2022. For the ten months, the company reported sales was SEK 21.86 million. Net loss was SEK 10.23 million.

Latest news about Prolight Diagnostics AB

Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	05-17	MT
Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-20	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-20	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-26	CI
Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Prolight Diagnostics AB Reports Earnings Results for the Ten Months Ended December 31, 2022	19/04/23	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Seven Months Ended September 30, 2022	29/11/22	CI
Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28/08/22	CI
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022	19/05/22	CI
Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	21/02/22	CI
Prolight Diagnostics AB signed an agreement to acquire Psyros Diagnostics Ltd for SEK 65 million.	19/01/22	CI
Prolight Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/11/21	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/08/21	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	04/05/21	CI
Prolight Diagnostics AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	09/02/21	CI

Chart Prolight Diagnostics AB

Duration

Period

More charts

Company Profile

Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.

Sector

Biotechnology & Medical Research

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
PROLIGHT DIAGNOSTICS AB	-55.81%	6.21M
EXACT SCIENCES CORPORATION	-31.90%	9.3B
GUARDANT HEALTH, INC.	-6.25%	3.1B
BGI GENOMICS CO., LTD.	-13.96%	2.17B
VERACYTE, INC.	-16.83%	1.75B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+72.82%	1.5B
CAREDX, INC	+29.17%	807M
SEEGENE, INC.	-2.62%	759M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-26.33%	532M
CURIOX BIOSYSTEMS CO., LTD	+4.97%	313M

Bio Diagnostics & Testing